Comparison of forward- and back-projection in vivo EPID dosimetry for VMAT treatment of the prostate

被引:29
|
作者
Bedford, James L. [1 ]
Hanson, Ian M.
Hansen, Vibeke N.
机构
[1] Inst Canc Res, Joint Dept Phys, Sutton SM2 5PT, Surrey, England
来源
PHYSICS IN MEDICINE AND BIOLOGY | 2018年 / 63卷 / 02期
关键词
portal dosimetry; EPID; VMAT; treatment plan; MODULATED ARC THERAPY; DOSE VERIFICATION; PORTAL DOSIMETRY; STATISTICS NOTES; RADIOTHERAPY; IMRT; IMPLEMENTATION; OPTIMIZATION; IMAGES; MODE;
D O I
10.1088/1361-6560/aa9c60
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the forward-projection method of portal dosimetry for volumetric modulated arc therapy (VMAT), the integrated signal at the electronic portal imaging device (EPID) is predicted at the time of treatment planning, against which the measured integrated image is compared. In the back-projection method, the measured signal at each gantry angle is back-projected through the patient CT scan to give a measure of total dose to the patient. This study aims to investigate the practical agreement between the two types of EPID dosimetry for prostate radiotherapy. The AutoBeam treatment planning system produced VMAT plans together with corresponding predicted portal images, and a total of 46 sets of gantry-resolved portal images were acquired in 13 patients using an iViewGT portal imager. For the forward-projection method, each acquisition of gantry-resolved images was combined into a single integrated image and compared with the predicted image. For the back-projection method, iViewDose was used to calculate the dose distribution in the patient for comparison with the planned dose. A gamma index for 3% and 3 mm was used for both methods. The results were investigated by delivering the same plans to a phantom and repeating some of the deliveries with deliberately introduced errors. The strongest agreement between forward-and back-projection methods is seen in the isocentric intensity/dose difference, with moderate agreement in the mean gamma. The strongest correlation is observed within a given patient, with less correlation between patients, the latter representing the accuracy of prediction of the two methods. The error study shows that each of the two methods has its own distinct sensitivity to errors, but that overall the response is similar. The forward-and back-projection EPID dosimetry methods show moderate agreement in this series of prostate VMAT patients, indicating that both methods can contribute to the verification of dose delivered to the patient.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Implementation of a Back-Projection Algorithm for 2D in Vivo Dosimetry with An EPID System
    Reyes, B. Hernandez
    Perez, E. Rodriguez
    Aquino, M. Sosa
    MEDICAL PHYSICS, 2016, 43 (06) : 3351 - 3351
  • [2] Accurate two-dimensional IMRT verification using a back-projection EPID dosimetry method
    Wendling, M
    Louwe, RJW
    McDermott, LN
    Sonke, JJ
    van Herk, M
    Mijnheer, BJ
    MEDICAL PHYSICS, 2006, 33 (02) : 259 - 273
  • [3] EPID dosimetry at the MR-Linac using a back-projection algorithm: proof of concept.
    Xirau, I. Torres
    Olaciregui-Ruiz, I.
    Mijnheer, B. J.
    Vivas-Maiques, B.
    van der Heide, U. A.
    Mans, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S155 - S156
  • [4] In vivo EPID dosimetry: 3D analysis applied to prostate VMAT treatments
    Villaggi, E.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S217 - S218
  • [5] A back-projection algorithm in the presence of an extra attenuating medium: towards EPID dosimetry for the MR-Linac
    Torres-Xirau, I.
    Olaciregui-Ruiz, I.
    Rozendaal, R. A.
    Gonzalez, P.
    Mijnheer, B. J.
    Sonke, J-J
    van der Heide, U. A.
    Mans, A.
    PHYSICS IN MEDICINE AND BIOLOGY, 2017, 62 (15): : 6322 - 6340
  • [6] Clinical results of an EPID-based in-vivo dosimetry for prostate cancer treated by VMAT
    Falco, M. D.
    Giancaterino, S.
    De Nicola, A.
    Perrotti, F.
    Menna, S.
    Fidanzio, A.
    Piermattei, A.
    Genovesi, D.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S706 - S706
  • [7] Sensing ability of EPID-based in vivo dosimetry for VMAT
    Tanooka, M.
    Tarutani, K.
    Doi, H.
    Suzuki, H.
    Takada, Y.
    Fujiwara, M.
    Toda, Y.
    Fujimoto, H.
    Miyashita, M.
    Okumura, A.
    Kagawa, K.
    Kamikonya, N.
    Yamakado, K.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S939 - S940
  • [8] Epid-based in vivo dosimetry for SBRT-VMAT treatment dose verification
    Cilla, S.
    Ianiro, A.
    Craus, M.
    Viola, P.
    Fidanzio, A.
    Azario, L.
    Greco, F.
    Grusio, M.
    Deodato, F.
    Macchia, G.
    Valentini, V.
    Morganti, A.
    Piermattei, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S772 - S773
  • [9] DVH criteria for prostate in vivo EPID dosimetry
    Van Oers, R. F. M.
    Van der Bijl, E.
    Olaciregui-Ruiz, I.
    Mans, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S114 - S114
  • [10] A DOSIMETRY COMPARISON OF FORWARD- AND INVERSE-PLANNED IMRT FOR PROSTATE CANCER IN THE CHHIP TRIAL
    Dearnaley, D. P.
    Naismith, O.
    Sumo, G.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S585 - S585